Dozens of research groups around the world are playing the long game, convinced that their experimental vaccines will be cheaper and more powerful than the ones leading the race today.
As summer draws to a close, four new developments in the treatment and understanding of the coronavirus have arisen in the United States and abroad.
The data from the city is on a far larger scale than previously released information, and includes all antibody test results reported to the city’s Department of Health.
In what may be the world’s most important math puzzle, researchers are trying to figure out how many people in a community must be immune before the coronavirus fades.
Dropping antibody counts aren’t a sign that our immune system is failing against the coronavirus, nor an omen that we can’t develop a viable vaccine.
During the pandemic, caregivers are being asked to do more than ever, from cleaning and cooking to teaching algebra.
Data from those tested at a storefront medical office in Queens is leading to a deeper understanding of the outbreak’s scope in New York.
Much remains unknown and mysterious, but these are some of the things we’re pretty sure of after half a year of this pandemic.
Some people who have survived the coronavirus describe being shunned by relatives and friends, rather than being celebrated.
A series of animal experiments may point the way to an effective human vaccine, scientists said.
Antibodies from Winter, a 4-year-old llama with great eyelashes, have neutralized coronavirus and other infections in lab experiments.
Talk of licensing people with the right antibodies, always ahead of the science, has faded as experts warn that they are still studying what level offers protection and how long it lasts.